Expert Interviews

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

The former president likely will have drug therapy to lower his testosterone levels, but there are other treatment options.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

Daniel Isaac, DO, MS, an oncologist/hematologist, discusses the publicly disclosed diagnosis of prostate cancer in former President Joe Biden.

Daniel Isaac, DO, MS, an oncologist/hematologist, discusses the publicly disclosed diagnosis of prostate cancer in former President Joe Biden.

Daniel Isaac, DO, MS, an oncologist/hematologist, discusses the publicly disclosed diagnosis of prostate cancer in former President Joe Biden.

Daniel Isaac, DO, MS, an oncologist/hematologist, discusses the publicly disclosed diagnosis of prostate cancer in former President Joe Biden.

Daniel Isaac, DO, MS, an oncologist/hematologist, discusses the publicly disclosed diagnosis of prostate cancer in former President Joe Biden.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

Joshua M. Liao, MD, spoke with Medical Economics following the ACP Internal Medicine Meeting last month about succeeding in value-based payment models.

Expert physicians discuss the urgent need to rebuild trust in vaccines amid rising skepticism and misinformation during the Trump administration, emphasizing the role of physicians in public health.

Joshua M. Liao, MD, outlines three critical factors primary care physicians should consider when deciding between value-based care models.

Joshua M. Liao, MD, explains how practices can effectively include non-clinical staff in performance incentives.

Joshua M. Liao discusses how primary care practices can adapt to models that reward care delivered outside traditional office visits.

Joshua M. Liao, MD, offers advice for practices trying to keep patients engaged and connected in a fragmented care environment.

Joshua M. Liao, MD, discusses the importance of patient attribution in value-based payment models — and how small practices can get it right.

AI tools are becoming more prevalent in back office operations, but they are also making inroads on the diagnostic side.

AI tools are becoming more prevalent in back office operations, but they are also making inroads on the diagnostic side.

AI tools are becoming more prevalent in back office operations, but they are also making inroads on the diagnostic side.

AI tools are becoming more prevalent in back office operations, but they are also making inroads on the diagnostic side.

AI tools are becoming more prevalent in back office operations, but they are also making inroads on the diagnostic side.

AI tools are becoming more prevalent in back office operations, but they are also making inroads on the diagnostic side.

AI tools are becoming more prevalent in back office operations, but they are also making inroads on the diagnostic side.

AI tools are becoming more prevalent in back office operations, but they are also making inroads on the diagnostic side.